Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Patients With Early Symptomatic Alzheimer's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
JAMA Neurol 2022 Dec 01;79(12)1250-1259, MJ Pontecorvo, M Lu, SC Burnham, AE Schade, JL Dage, S Shcherbinin, EC Collins, JR Sims, MA MintunFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.